{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:38:14Z","timestamp":1791999494617,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.sxmr.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T13:17:18Z","timestamp":1507900638000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intralesional Injection of Collagenase Clostridium histolyticum May Increase the Risk of Late-Onset Penile Fracture"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3213","authenticated-orcid":false,"given":"Jonathan A.","family":"Beilan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Wallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Baumgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-3948","authenticated-orcid":false,"given":"Justin L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2017.07.011_bib1","first-page":"199","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie's disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib2","first-page":"2350","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campbell","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ucl.2007.08.017","article-title":"Peyronie's disease","volume":"34","author":"Taylor","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.sxmr.2017.07.011_bib5","first-page":"2858","article-title":"Penile sonographic and clinical characteristics in men with Peyronie's disease","volume":"6","author":"Smith","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.011_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0090-4295(80)90028-X","article-title":"Clostridial collagenase and Peyronie's disease","volume":"15","author":"Gelbard","year":"1980","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2017.07.011_bib8","first-page":"280","article-title":"The use of collagenase in the treatment of Peyronie's disease","volume":"134","author":"Gelbard","year":"1985","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib9","author":"Endo Pharmaceuticals"},{"key":"10.1016\/j.sxmr.2017.07.011_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2016.07.026","article-title":"Suspected penile fracture after Xiaflex injection and use of a VED","volume":"98","author":"Beilan","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2017.07.011_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/sm2.49","article-title":"Excision and patch grafting of a lateral Peyronie's plaque-utilizing a longitudinal \u201cwindow\u201d approach","volume":"3","author":"Lue","year":"2015","journal-title":"Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib12","first-page":"684","article-title":"Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase Clostridium histolyticum for Peyronie's Disease","volume":"13","author":"Yafi","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/smrj.54","article-title":"The history of collagenase Clostridium histolyticum","volume":"3","author":"Yang","year":"2015","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2017.07.011_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies","volume":"116","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.011_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/andr.12302","article-title":"Survey of patient and partner satisfaction following collagenase Clostridium histolyticum treatment for Peyronie's disease","volume":"5","author":"Anaissie","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.sxmr.2017.07.011_bib16","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.esxm.2017.02.001","article-title":"Changes in the effects of Peyronie's disease after treatment with collagenase Clostridium histolyticum: male patients and their female partners","volume":"5","author":"Goldstein","year":"2017","journal-title":"Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sxmr.2017.03.005","article-title":"Collagenase Clostridium histolyticum in the treatment of urologic disease: current and future impact","volume":"6","author":"Gabrielson","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2017.07.011_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/PPA.S113507","article-title":"Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives","volume":"11","author":"Kuhlmann","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.sxmr.2017.07.011_bib19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-015-0441-7","article-title":"Collagenase Clostridium histolyticum: a review in Peyronie's disease","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.sxmr.2017.07.011_bib20","first-page":"56","article-title":"Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib21","first-page":"180","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study","volume":"5","author":"Jordan","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bju.13120","article-title":"Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD)","volume":"116","author":"Carson","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2017.07.011_bib23","first-page":"2268","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie's disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2017.07.011_bib24","first-page":"248","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2017.07.011_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2016.04.049","article-title":"Peyronie's disease and injectable collagenase Clostridium histolyticum: safety, efficacy, and improvements in subjective symptoms","volume":"94","author":"Yang","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2017.07.011_bib26","first-page":"1051","article-title":"Restoration of penile function and patient satisfaction with intralesional collagenase Clostridium histolyticum Injection for Peyronie's disease","volume":"195","author":"Ziegelmann","year":"2016","journal-title":"J\u00a0Urol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052117300963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T14:36:57Z","timestamp":1672756617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052117300963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2050052117300963"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.07.011","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional Injection of Collagenase Clostridium histolyticum May Increase the Risk of Late-Onset Penile Fracture","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}